Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiersTransitioning to Adult Care in DMD: Strategies for Long-Term Support
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiersSupporting Adults With DMD: A Guide to Acute and Long-Term Planning
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiersThe Complexities of DMD: Optimizing Multidisciplinary Care
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiersInvestigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiersReducing the Burden of gMG with a Novel B-Cell Therapy
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiersExploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
- 3 questions
Hand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)
Medical Industry FeatureHand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)
CV Risk in Patients with Narcolepsy: See the Data
Medical Industry FeatureCV Risk in Patients with Narcolepsy: See the Data
Early Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care
Medical Industry FeatureEarly Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care
Advancements in Understanding ALS Treatment
Medical Industry FeatureAdvancements in Understanding ALS Treatment
From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Medical Industry FeatureFrom Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Investigating a gMG Therapy, Part 1: The MG-ADL Results
Medical Industry FeatureInvestigating a gMG Therapy, Part 1: The MG-ADL Results
- 05/08/2025
- 05/08/2025
- 05/08/2025
- 05/08/2025
- 05/08/2025
- 05/08/2025